Idera Pharmaceuticals, Inc.
IDRA · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $12 | $33 | $33 | $40 |
| Short-Term Investments | $0 | $0 | $4 | $3 |
| Receivables | $4 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $1 | $4 | $3 |
| Total Curr. Assets | $18 | $34 | $41 | $46 |
| Property Plant & Equip (Net) | $1 | $1 | $1 | $1 |
| Goodwill | $11 | $0 | $0 | $0 |
| Intangibles | $72 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $83 | $1 | $1 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $101 | $35 | $42 | $47 |
| Liabilities | – | – | – | – |
| Payables | $5 | $1 | $0 | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $16 | $4 | $7 | $54 |
| Total Curr. Liab. | $21 | $5 | $7 | $55 |
| LT Debt | $0 | $1 | $1 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $3 | $0 | $0 | $0 |
| Other NC Liab. | $37 | $0 | $126 | $3 |
| Total NC Liab. | $41 | $1 | $127 | $4 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $62 | $5 | $134 | $59 |
| Equity | – | – | – | – |
| Pref Stock | $34 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$759 | -$735 | -$834 | -$721 |
| AOCI | -$0 | $0 | $0 | -$1 |
| Other Equity | $736 | $765 | $742 | $710 |
| Total Equity | $12 | $29 | -$91 | -$11 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $74 | $35 | $42 | $47 |
| Net Debt | -$11 | -$32 | -$32 | -$39 |